Signaturefd, LLC Exelixis, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 6,138 shares of EXEL stock, worth $223,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,138

Previous 5,472 12.17%

Holding current value

$223,300

Previous $122,000 30.33%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$21.96 - $27.6 $14,625 - $18,381	666 Added 12.17%	6,138 $159,000
Q2 2024 Jul 29, 2024	BUY	$20.34 - $23.73 $44,117 - $51,470	2,169 Added 65.67%	5,472 $122,000
Q1 2024 May 03, 2024	BUY	$20.17 - $23.93 $2,823 - $3,350	140 Added 4.43%	3,303 $78,000
Q4 2023 Jan 31, 2024	SELL	$19.25 - $24.13 $27,219 - $34,119	-1,414 Reduced 30.89%	3,163 $75,000
Q3 2023 Nov 03, 2023	BUY	$19.04 - $22.74 $12,718 - $15,190	668 Added 17.09%	4,577 $100,000
Q2 2023 Aug 01, 2023	SELL	$18.17 - $20.48 $181 - $204	-10 Reduced 0.26%	3,909 $74,000
Q1 2023 Apr 28, 2023	BUY	$16.3 - $19.41 $18,777 - $22,360	1,152 Added 41.63%	3,919 $76,000
Q4 2022 Jan 27, 2023	BUY	$14.96 - $17.39 $9,260 - $10,764	619 Added 28.82%	2,767 $44,000
Q3 2022 Nov 08, 2022	BUY	$15.68 - $22.27 $26,953 - $38,282	1,719 Added 400.7%	2,148 $34,000
Q2 2022 Aug 10, 2022	BUY	$17.44 - $23.16 $3,801 - $5,048	218 Added 103.32%	429 $9,000
Q1 2022 May 02, 2022	BUY	$17.03 - $22.67 $1,055 - $1,405	62 Added 41.61%	211 $5,000
Q4 2021 Jan 25, 2022	BUY	$15.84 - $21.88 $1,900 - $2,625	120 Added 413.79%	149 $3,000
Q3 2021 Oct 28, 2021	SELL	$16.3 - $21.14 $2,575 - $3,340	-158 Reduced 84.49%	29 $1,000
Q2 2021 Jul 26, 2021	BUY	$17.95 - $25.56 $1,687 - $2,402	94 Added 101.08%	187 $3,000
Q1 2021 Apr 30, 2021	BUY	$20.53 - $25.22 $1,026 - $1,261	50 Added 116.28%	93 $2,000
Q4 2020 Feb 11, 2021	SELL	$18.39 - $24.8 $1,765 - $2,380	-96 Reduced 69.06%	43 $1,000
Q3 2020 Nov 03, 2020	BUY	$20.67 - $26.94 $1,364 - $1,778	66 Added 90.41%	139 $3,000
Q2 2020 Jul 30, 2020	SELL	$16.46 - $27.42 $3,061 - $5,100	-186 Reduced 71.81%	73 $2,000
Q1 2020 Apr 23, 2020	BUY	$14.46 - $21.8 $621 - $937	43 Added 19.91%	259 $4,000
Q4 2019 Feb 05, 2020	SELL	$15.15 - $18.89 $22,528 - $28,089	-1,487 Reduced 87.32%	216 $4,000
Q3 2019 Oct 16, 2019	SELL	$17.68 - $22.65 $10,325 - $13,227	-584 Reduced 25.54%	1,703 $30,000
Q2 2019 Jul 31, 2019	BUY	$18.93 - $24.75 $39,355 - $51,455	2,079 Added 999.52%	2,287 $49,000
Q4 2018 Feb 13, 2019	BUY	$13.65 - $21.8 $1,037 - $1,656	76 Added 57.58%	208 $4,000
Q3 2018 Nov 15, 2018	BUY	$15.87 - $22.4 $31 - $44	2 Added 1.54%	132 $2,000
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $371 - $449	20 Added 18.18%	130 $3,000
Q1 2018 May 08, 2018	BUY	$22.15 - $31.89 $2,436 - $3,507	110 New	110 $2,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account